The Association Between Rs3756261 A/G Gene Polymorphism and the Risk of Ankylosing Spondylitis in a Chinese Han Population

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2024 Apr 2

PMID 38562211

Authors

Hui Zhang

Wei Jiang

Affiliations

Soon will be listed here.

Abstract

Background: Epidermal growth factor (EGF) is a potent pro-angiogenic molecule promoting the angiogenic phenotype of ankylosing spondylitis (AS). Studies demonstrated that rs3756261 polymorphism was associated with the risk of inflammatory diseases, but not including AS.

Methods: To investigate the association between rs3756261 polymorphism and the risk of AS, we genotyped the rs3756261 polymorphism in 208 patients with AS and 412 controls in a Chinese Han population using a custom-by-design 48-Plex SNP scan Kit. The serum EGF levels were measured using an enzyme-linked immunosorbent assay in 208 AS patients and 412 controls.

Results: Our data indicated that rs3756261 polymorphism was associated with an increased risk of AS in the Chinese Han population. Stratified analyses indicated that the rs3756261 polymorphism elevated the risk of AS among the males, smokers, drinkers and those aged <30 years. In addition, the rs3756261 polymorphism was related to increased CRP and HLA-B27 levels in AS patients. Next, we found that the average serum levels of EGF were significantly higher in AS patients compared with controls. Meanwhile, EGF serum levels were significantly higher in AG genotype carriers when compared with AA genotype carriers in AS patients.

Conclusion: In conclusion, this study indicated that rs3756261 polymorphism was associated with the risk of AS and EGF serum levels in a Chinese Han population.

References

Levin E . Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol. 2003; 17(3):309-17. DOI: 10.1210/me.2002-0368. View

Ding N, Hu Y, Zeng Z, Liu S, Liu L, Yang T . Case-only designs for exploring the interaction between FCRL4 gene and suspected environmental factors in patients with ankylosing spondylitis. Inflammation. 2014; 38(2):632-6. DOI: 10.1007/s10753-014-9970-6. View

Yildiz F, Dinkci S, Erken E . Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study. Arch Rheumatol. 2023; 38(2):238-248. PMC: 10481690. DOI: 10.46497/ArchRheumatol.2023.9468. View

Kidd B, Moore K, Walters M, Smith J, Cawley M . Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis. Ann Rheum Dis. 1989; 48(2):92-8. PMC: 1003691. DOI: 10.1136/ard.48.2.92. View

Ahsan T, Erum U, Jabeen R, Khowaja D . Ankylosing Spondylitis: A rheumatology clinic experience. Pak J Med Sci. 2016; 32(2):365-8. PMC: 4859024. DOI: 10.12669/pjms.322.9366. View

van der Linden S, VALKENBURG H, Cats A . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27(4):361-8. DOI: 10.1002/art.1780270401. View

Harari P . Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer. 2004; 11(4):689-708. DOI: 10.1677/erc.1.00600. View

Yarden Y . The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001; 37 Suppl 4:S3-8. DOI: 10.1016/s0959-8049(01)00230-1. View

Butt C, Lim S, Greenwood C, Rahman P . VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord. 2007; 8:1. PMC: 1781940. DOI: 10.1186/1471-2474-8-1. View

10.

Przepiera-Bedzak H, Fischer K, Brzosko M . Serum VEGF, EGF, basic FGF, and acidic FGF levels and their association with disease activity and extra‑articular symptoms in ankylosing spondylitis. Pol Arch Med Wewn. 2016; 126(4):290-2. DOI: 10.20452/pamw.3341. View

11.

Babaie F, Ebrazeh M, Hemmatzadeh M, Mohammadi F, Shabgah A, Hajaliloo M . Association analysis of ERAP1 gene single nucleotide polymorphism in susceptibility to ankylosing spondylitis in Iranian population. Immunol Lett. 2018; 201:52-58. DOI: 10.1016/j.imlet.2018.11.002. View

12.

Seo J, Lee S, Kim S, Ryu W, Sa K, Kim S . Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis. Rheumatology (Oxford). 2005; 44(10):1299-302. DOI: 10.1093/rheumatology/kei013. View

13.

Azuma N, Katada Y, Kitano S, Sekiguchi M, Kitano M, Nishioka A . Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome. Mod Rheumatol. 2013; 24(4):626-32. DOI: 10.3109/14397595.2013.850766. View

14.

Tam L, Gu J, Yu D . Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010; 6(7):399-405. DOI: 10.1038/nrrheum.2010.79. View

15.

Francois R, Gardner D, Degrave E, Bywaters E . Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum. 2000; 43(9):2011-24. DOI: 10.1002/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y. View

16.

Ceponis A, Konttinen Y, Imai S, Tamulaitiene M, Li T, Xu J . Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol. 1998; 37(2):170-8. DOI: 10.1093/rheumatology/37.2.170. View

17.

Azuma N, Katada Y, Kitano S, Sekiguchi M, Kitano M, Nishioka A . Rapid decrease in salivary epidermal growth factor levels in patients with Sjögren's syndrome: A 3-year follow-up study. Mod Rheumatol. 2015; 25(6):876-82. DOI: 10.3109/14397595.2015.1034941. View

18.

Koch A . Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998; 41(6):951-62. DOI: 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D. View

19.

Mahmoudi M, Aslani S, Nicknam M, Karami J, Jamshidi A . New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Mod Rheumatol. 2016; 27(2):198-209. DOI: 10.1080/14397595.2016.1206174. View

20.

Kusada J, Otsuka T, Matsui N, Hirano T, Asai K, Kato T . Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids. Nihon Seikeigeka Gakkai Zasshi. 1993; 67(9):859-65. View